Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-10-26

Clinical Trial Update: Study on Ex-PRESS Implantation Combined With Phacoemulsification in Primary Angle-closure Glaucoma [NA]

View source ↗

Summary

Clinical trial update on Ex-PRESS Micro-Shunt implantation combined with phacoemulsification for primary angle-closure glaucoma; no study results are provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ex-PRESS Micro-Shunt (ex-press micro-shunt)

Snippet

Sponsor: Wenzhou Medical University | Conditions: Glaucoma, Angle-Closure | NA | Status: UNKNOWN